Stock GE9 GENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Quotes Genmab A/S Deutsche Boerse AG

Equities

GE9

DK0010272202

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG
Other stock markets
 01:11:05 29/06/2024 am IST 		5-day change 1st Jan Change
232.7 EUR -1.90% Intraday chart for Genmab A/S -4.24% -19.03%
28/06 Would you like some more inflation? Our Logo
28/06 Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU MT

Quotes 5-day view

Delayed Quote Deutsche Boerse AG
Genmab A/S(GE9) : Historical Chart (5-day)
  25/06/2024 26/06/2024 27/06/2024 28/06/2024
Last 238.6 € 239.6 € 237.2 € 232.7 €
Volume 2 2 10 11
Change +0.34% +0.42% -1.00% -1.90%
Opening 238.30 240.50 239.10 237.70
High 238.60 244.00 239.20 237.70
Low 238.30 239.60 237.20 232.70

Performance

1 day-1.90%
1 week-4.24%
Current month-9.91%
1 month-9.31%
3 months-15.60%
6 months-18.98%
Current year-19.03%
1 year-31.78%
3 years-33.99%
5 years+44.27%
10 years+640.68%

Volumes

markets
Daily volume
11
Estimated daily volume
11
Avg. Volume 20 sessions
16
Daily volume ratio
0.69
Avg. Volume 20 sessions
3 723.20
Avg. Volume 20 sessions USD
3 987.99
Record volume 1
9 040
Record volume 2
8 900
Record volume 3
8 135
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (EUR)
110 710 746 302
Capitalization (USD)
15 911 569 880
Net sales (DKK)
16 474 000 000
Net sales (USD)
2 367 676 228
Number of employees
2 286
Sales / Employee (DKK)
7 206 474
Sales / Employee (USD)
1 035 729
Free-Float
98.51 %
Free-Float capitalization (EUR)
113 649 252 918
Free-Float capitalization (USD)
16 333 897 928
Average Daily Capital Traded
0%

Highs and lows

1 week
232.70
Extreme 232.7
244.00
1 month
232.70
Extreme 232.7
264.70
Current year
232.70
Extreme 232.7
296.50
1 year
232.70
Extreme 232.7
372.00
3 years
232.70
Extreme 232.7
445.10
5 years
145.00
Extreme 145
445.10
10 years
27.55
Extreme 27.554
445.10

Indicators

Moving average 5 days
237.18
Moving average 20 days
247.88
Moving average 50 days
258.74
Moving average 100 days
263.85
Price spread / (MMA5)
+1.93%
Price spread / (MMA20)
+6.52%
Price spread / (MMA50)
+11.19%
Price spread / (MMA100)
+13.39%
STIM
RSI 9 days
33.26
RSI 14 days
34.30

Sector Comparison - Bio Therapeutic Drugs

Name Change 5d. change 1st Jan change 1-year change Capi.
GENMAB A/S Stock Genmab A/S
-1.90%-4.24%-19.03%-31.78% 15.91B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-0.80%+0.00%+15.20%+33.62% 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.02%-0.20%+19.67%+50.14% 113B
ARGENX SE Stock argenx SE
-1.87%+9.90%+18.95%+16.51% 26.02B
BIONTECH SE Stock BioNTech SE
-0.02%-5.06%-23.86%-24.83% 19.39B
BEIGENE, LTD. Stock BeiGene, Ltd.
-2.00%-8.61%-20.90%-20.68% 15.09B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-0.36%-3.21%-46.14%-37.44% 15.06B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+0.03%-1.69%+63.85%+41.18% 14.93B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.50%+2.30%+4.49%+45.19% 13.85B
INSMED INCORPORATED Stock Insmed Incorporated
+0.07%-1.46%+116.20%+232.51% 10.8B
ZEALAND PHARMA A/S Stock Zealand Pharma A/S
+2.65%+16.29%+139.15%+279.79% 9.06B
VAXCYTE, INC. Stock Vaxcyte, Inc.
-4.14%+0.76%+20.24%+46.79% 8.22B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-0.83%+3.94%-26.39%-36.91% 8.07B
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
+0.72%+6.67%+8.28%+56.79% 7.82B
CEREVEL THERAPEUTICS HOLDINGS, INC. Stock Cerevel Therapeutics Holdings, Inc.
+0.96%-1.82%-3.56%+25.54% 7.45B
HALOZYME THERAPEUTICS, INC. Stock Halozyme Therapeutics, Inc.
+1.41%+1.57%+41.67%+53.01% 6.66B
Average-0.22%+1.30%+19.24%+45.59%
Weighted average by Cap.-0.41%+0.47%+15.96%+38.00%

Historical data

DateOpeningHighLowEnd-of-dayVolume

Last transactions

127f932a701381bf635e1156862941e.vlC0fm-Pkzq7cn_FvJ31tLeRPylcSXYXkREjGC0mtzo.jADREAXg0k7WREyE89KlgfD1ZWwrcUJO0HtXaWdJ2HvwPoc5FtzMDd08HA
DatePriceVolumeDaily volume
08:24:55 pm 233.1 5 11
03:00:29 pm 237.7 1 6

Chart Genmab A/S

Chart Genmab A/S
More charts

Monthly variations

Annual change

2024-19.03%
2023-27.84%
2022+13.77%
2021+7.72%
2020+63.81%
2019+40.16%
2018+1.98%
2017-11.59%
2016+24.54%
2015+157.97%
2014+72.49%
2013+173.85%
2012+188.00%
2011-59.18%
2010-19.41%
2009-61.43%
2008-31.05%
2007-19.52%
2006+181.10%
2005+34.34%
2004+107.85%
2003+109.00%
2002-86.36%
2001-5.00%
2000-25.70%
  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. GE9 Stock
  5. Quotes Genmab A/S